Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Drug averts Parkinson’s disease in fruit flies, suggesting new approach for humans

12.11.2002


Scientists at the University of Pennsylvania have averted the onset of neurodegenerative disease in fruit flies by administering medication to flies genetically predisposed to a disorder akin to Parkinson’s disease.



The result suggests a new approach to the treatment of human disorders including Parkinson’s and Alzheimer’s diseases. Penn biologist Nancy M. Bonini and graduate student Pavan K. Auluck report the finding in the November issue of Nature Medicine.

Parkinson’s disease is the second most common human neurodegenerative disorder, characterized by tremors, postural rigidity and progressive deterioration of dopaminergic neurons in specific areas of the brain. Despite the evolutionary gulf separating humans and fruit flies, neurotoxicity unfolds in a similar manner in both species. Like humans, Drosophila melanogaster experiences neuronal loss upon expression of alpha-synuclein, a protein implicated in the onset of Parkinson’s disease in both species.


"Medications now prescribed to people with Parkinson’s disease, such as levodopa, bromocriptine and deprenyl, relieve symptoms by rescuing neurons compromised by the disease," said Bonini, Penn professor of biology and investigator with the Howard Hughes Medical Institute. "Our studies suggest that a new class of drugs might prevent neurodegenerative disorders by fortifying these neurons even before the onset of disease."

Bonini and Auluck fed flies a naturally occurring antibiotic called geldanamycin. When fed geldanamycin-supplemented food as adults, flies with a genetic susceptibility to neurodegenerative disease -- flies that would normally experience a 50 percent loss of dopaminergic neurons by 20 days of age -- maintained normal numbers of these neurons.

Geldanamycin tweaks the activity of Hsp90, one of a class of proteins known as molecular chaperones. Bonini, Auluck and colleagues showed last year that molecular chaperones can block the progression of neurodegenerative disease in Drosophila, suggesting that diseases like Parkinson’s and Alzheimer’s may result from reduced chaperone levels and might be averted by pharmacologically boosting chaperone activity.

Bonini cautions that there are limitations of geldanamycin itself, derivatives of which are now undergoing clinical trials as possible antitumor agents. However, she says these findings should stimulate chemists and pharmaceutical researchers on the trail of a new class of drugs that, by bolstering molecular chaperones, could prevent neurodegenerative disease from ever taking hold

"These studies have revealed a drug that can fully protect against the toxicity of alpha-synuclein to dopaminergic neurons in Drosophila," Bonini and Auluck write in Nature Medicine. "Geldanamycin and its derivatives warrant further exploration as cytoprotective agents for the treatment of neurodegenerative diseases involving alpha-synuclein toxicity, including Parkinson’s disease."


Bonini and Auluck’s work is funded by grants from the David and Lucile Packard Foundation, the National Institute on Aging, the National Institutes of Health and the Alzheimer’s Association.


Steve Bradt | EurekAlert!
Further information:
http://www.upenn.edu/

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Gold shines through properties of nano biosensors

17.08.2017 | Physics and Astronomy

Greenland ice flow likely to speed up: New data assert glaciers move over sediment, which gets more slippery as it gets wetter

17.08.2017 | Earth Sciences

Mars 2020 mission to use smart methods to seek signs of past life

17.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>